Open AccessCinacalcet Treatment for Secondary Hyperparathyroidism in Dialysis Patients: An Observational Study in Routine Clinical Practice
Author(s) -
Jordi Bover,
Rafael Pérez-García,
Manuel Molina,
B. Benavides,
Francisco Ariza,
José Luís San Miguel,
Fernando Tornero,
JoséVicente Torregrosa
Publication year - 2010
Publication title -
nephron clinical practice
Language(s) - English
Resource type - Journals
ISSN - 1660-2110
DOI - 10.1159/000319882
Subject(s) - cinacalcet , medicine , secondary hyperparathyroidism , urology , dialysis , kidney disease , vitamin d and neurology , gastroenterology , adverse effect , parathyroid hormone , tolerability , calcium
Cinacalcet reduces intact parathyroid hormone (iPTH), Ca and P serum levels in patients with secondary hyperparathyroidism (SHPT).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom